CELLULAR LONGEVITY Trademark

Trademark Overview

On Friday, April 22, 2022, a trademark application was filed for CELLULAR LONGEVITY with the United States Patent and Trademark Office. The USPTO has given the CELLULAR LONGEVITY trademark a serial number of 97377260. The federal status of this trademark filing is EX PARTE APPEAL TERMINATED as of Monday, November 3, 2025. This trademark is owned by Cellular Longevity, Inc.. The CELLULAR LONGEVITY trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of age-associated disease

Medical testing for diagnostic or treatment purposes
cellular longevity

General Information

Serial Number97377260
Word MarkCELLULAR LONGEVITY
Filing DateFriday, April 22, 2022
Status762 - EX PARTE APPEAL TERMINATED
Status DateMonday, November 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of age-associated disease
Goods and ServicesMedical testing for diagnostic or treatment purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCellular Longevity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2022NEW APPLICATION ENTERED
Thursday, April 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 13, 2022ASSIGNED TO EXAMINER
Friday, December 16, 2022NON-FINAL ACTION WRITTEN
Friday, December 16, 2022NON-FINAL ACTION E-MAILED
Friday, December 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 15, 2023NON-FINAL ACTION WRITTEN
Saturday, April 15, 2023NON-FINAL ACTION E-MAILED
Saturday, April 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 14, 2023NON-FINAL ACTION WRITTEN
Monday, August 14, 2023NON-FINAL ACTION E-MAILED
Monday, August 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 5, 2023NON-FINAL ACTION WRITTEN
Thursday, October 5, 2023NON-FINAL ACTION E-MAILED
Thursday, October 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 20, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, April 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 4, 2024FINAL REFUSAL WRITTEN
Thursday, July 4, 2024FINAL REFUSAL E-MAILED
Thursday, July 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 23, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 23, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 24, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, December 24, 2024EX PARTE APPEAL-INSTITUTED
Monday, February 24, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, April 15, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, June 9, 2025EXAMINERS STATEMENT - COMPLETED
Monday, June 9, 2025EXAMINERS STATEMENT E-MAILED
Monday, June 9, 2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Monday, August 18, 2025EX PARTE APPEAL-REFUSAL AFFIRMED
Monday, November 3, 2025EXPARTE APPEAL TERMINATED

Related Keywords

longevity cellular treatment testing diagnostic medical purposes associated preparations prevention pharmaceutical disease